
ReWrite
Your desired genetic code with our expert stem cell genome editing services
We accelerate your research by providing iPSC Generation & Genome Editing Services
Discover our services
- Reprogramming (iPSC generation)From fibroblasts, PBMCs, urine-derived or epithelial cells, with non-integrating Sendai vectors.Learn more
- Genome editingSNVs, knock-ins, reporters and knockouts with CRISPR-Cas9 delivered as RNP.Learn more
- Free consultationDiscuss your model and the edit you need with one of our scientists.Book a meeting

Who we are
ReWrite is an independent start-up founded by scientists from the Stem Cell Institute Leuven
Our founder and our CSO built their expertise at the Stem Cell Institute Leuven (SCIL), founded in 2005 at KU Leuven, where they spent years reprogramming and genome editing human stem cells. ReWrite brings that experience to your lab, with the enthusiasm and entrepreneurial spirit of a dedicated team led by Prof. em. Catherine Verfaillie and spearheaded by Dr. Arefe Nami.
Find out moreWhy ReWrite is a trusted choice
- Expert-driven, efficient and affordable; scientists with years of hands-on experience.
- Streamlined process with minimum time-to-results.
- Comprehensive quality control; genomic integrity, pluripotency, off-target analysis and more.
- Consistent and reliable outcomes; with intermediate reports along the way.
- Tailored to your needs based on deep scientific discussions.

Outstanding track record of ReWrite scientists
(performed at the Stem Cell Institute Leuven)
- studies demonstrating our expertiseSee selected publications
- +41
- genetically edited stem cells
- +106
- reprogrammed iPSC lines
- +62
How we work
From first call to validated cells
- 01Free consultationWe discuss your model, the edit you need and how you will read it out.
- 02Design & quoteStrategy, QC package and timeline, agreed in writing.
- 03Reprogramming & editingIntermediate reports keep you informed of progress.
- 04QC & deliveryValidated lines shipped with full documentation.
Project FIT: Muscle Stem Cell Therapy
Within the Euregio Meuse-Rhine, ReWrite is collaborating with leading universities and innovative companies on Project FIT (IMR6-00132). We are advancing personalised therapies using patient-derived muscle stem cells to treat rare disorders, age-related muscle loss, and heart diseases.
This initiative brings together expertise from Maastricht, Leuven, Liège, Hasselt, and Aachen to deliver high-quality, affordable treatments for conditions where effective options are currently lacking.
Project co-funded by the European Union and the Walloon Region.

Publications
Selected work of our scientists
Research performed at the Stem Cell Institute Leuven (all rights belong to KU Leuven) by scientists who are now part of ReWrite.
Planning an iPSC or genome editing project?
Tell us what you need – we are happy to discuss your project.
